API

Dapagliflozin

Dapagliflozin•Cardiometabolic diseases
CAS: 461432-26-8
MF: C21H25ClO6
MW: 408.88
Indications
Therapeutic Target
MR;SGLT2
Usage
Specification
Product Description

Overview

Physicochemical Properties

MSDS Information

Experimental Data

Pharmacodynamics

Mechanism Of Action

Similar Products